1. Home
  2. IMNN vs PAVS Comparison

IMNN vs PAVS Comparison

Compare IMNN & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$0.54

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

HOLD

Current Price

$2.27

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNN
PAVS
Founded
1982
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.5M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
IMNN
PAVS
Price
$0.54
$2.27
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $15.20
N/A
AVG Volume (30 Days)
133.1K
★ 453.6K
Earning Date
11-12-2026
12-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$541.46
Revenue Next Year
N/A
$1.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.02
52 Week High
$4.35
$26.69

Technical Indicators

Market Signals
Indicator
IMNN
PAVS
Relative Strength Index (RSI) 23.75 37.10
Support Level $0.50 $1.10
Resistance Level $1.28 $4.41
Average True Range (ATR) 0.10 0.46
MACD -0.01 -0.02
Stochastic Oscillator 9.96 24.54

Price Performance

Historical Comparison
IMNN
PAVS

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

Share on Social Networks: